These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1121934)

  • 21. In vitro responses of mammalian cells to drug-induced potentially lethal and sublethal damage.
    Barranco SC
    Cancer Treat Rep; 1976 Dec; 60(12):1799-810. PubMed ID: 1026336
    [No Abstract]   [Full Text] [Related]  

  • 22. The mechanisms of action of antitumor compounds.
    Belousova AK
    Natl Cancer Inst Monogr; 1977 Mar; (45):183-93. PubMed ID: 73135
    [No Abstract]   [Full Text] [Related]  

  • 23. Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo.
    Caffrey PB; Zhang Y; Frenkel GD
    Anticancer Res; 1998; 18(4C):3021-5. PubMed ID: 9713503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tumour chemotherapy. XXXIX Synthesis of 2-methyl-5-bis (beta-chloroethyl) aminophenylalanine and 2-bis (beta-chloroethyl)-aminomethyl-5-nitrophenylalanine (author's transl)].
    Zheng YY; Ren YF
    Yao Xue Xue Bao; 1979 Nov; 14(11):676-81. PubMed ID: 552207
    [No Abstract]   [Full Text] [Related]  

  • 25. ANTITUMOR EFFECT OF OLIVOMYCIN COMBINED WITH VARIOUS SYNTHETIC CYTOTOXIC DRUGS.
    ROSSOLIMO OK; LEPESHKINA GN
    Fed Proc Transl Suppl; 1964; 23():484-6. PubMed ID: 14185884
    [No Abstract]   [Full Text] [Related]  

  • 26. Sensitivity of proliferating cultured murine pancreatic tumor cells to selected antitumor agents.
    Wilkoff LJ; Dulmadge EA
    J Natl Cancer Inst; 1986 Nov; 77(5):1163-9. PubMed ID: 3464801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On sensitivity to sarcolysine of Ehrlich's ascites tumors in mice "vaccinated" with treated tumor cells from animals previously treated with sarcolysine alone or with other antineoplastic drugs (thioguanine, actinomycin D)].
    Bonmassar E; Melan F; Testorelli C
    Arch Ital Patol Clin Tumori; 1968; 11(1):229-44. PubMed ID: 5745130
    [No Abstract]   [Full Text] [Related]  

  • 28. EFFECT OF CERTAIN ANTITUMOR DRUGS ON REGENERATION IN RABBITS.
    SAMOILOV NN
    Fed Proc Transl Suppl; 1964; 23():37-8. PubMed ID: 14112002
    [No Abstract]   [Full Text] [Related]  

  • 29. IN VITRO CULTURE OF YOSHIDA SARCOMA CELLS: METHODS FOR DETERMINING ACQUIRED RESISTANCE TO DRUGS.
    SAKURAI Y
    Natl Cancer Inst Monogr; 1964 Dec; 16():207-39. PubMed ID: 14235655
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of antineoplastic agents on the accumulation of collargol in cells of the reticuloendothelial system].
    Korol'chuk VP; Iushkov SF
    Farmakol Toksikol; 1970; 33(6):707-11. PubMed ID: 4996581
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
    Nath K; Nelson DS; Putt ME; Leeper DB; Garman B; Nathanson KL; Glickson JD
    PLoS One; 2016; 11(6):e0157125. PubMed ID: 27285585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A new anti-cancer agent K-18 (conjugate of human IgG and melphalan). (II). Its inhibitory effects on in vitro DNA synthesis of human tumor cells].
    Nio Y; Tsuchitani T; Imai S; Kan N; Ohgaki K; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1986 Oct; 21(9):2274-83. PubMed ID: 3102654
    [No Abstract]   [Full Text] [Related]  

  • 33. Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.
    Salmon SE; Hamburger AW; Soehnlen B; Durie BG; Alberts DS; Moon TE
    N Engl J Med; 1978 Jun; 298(24):1321-7. PubMed ID: 77475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, structure-activity relationship and biological evaluation of novel nitrogen mustard sophoridinic acid derivatives as potential anticancer agents.
    Li DD; Dai LL; Zhang N; Tao ZW
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4092-6. PubMed ID: 26299348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experimental studies on the action of various cytostatic substances on the growth of aerobic and anaerobic microorganisms].
    Krebs D; Bloss H
    Zentralbl Bakteriol Orig; 1966 Aug; 200(4):468-79. PubMed ID: 4169936
    [No Abstract]   [Full Text] [Related]  

  • 36. THE TREATMENT OF MALIGNANT DISEASE BY REGIONAL CHEMOTHERAPY.
    JOHNSTON ID
    Ulster Med J; 1963 Dec; 32(2):151-9. PubMed ID: 14105942
    [No Abstract]   [Full Text] [Related]  

  • 37. Resistance and cross-resistance of Escherichia coli mutants to anticancer agents: nitrogen mustard and nitromin.
    WOODY PL; MANDELL JD; GREENBERG J
    Radiat Res; 1961 Sep; 15():290-7. PubMed ID: 13786618
    [No Abstract]   [Full Text] [Related]  

  • 38. Bendamustine overcomes resistance to melphalan in myeloma cell lines by inducing cell death through mitotic catastrophe.
    Cives M; Ciavarella S; Rizzo FM; De Matteo M; Dammacco F; Silvestris F
    Cell Signal; 2013 May; 25(5):1108-17. PubMed ID: 23380051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential lethal effect of cytotoxic agents on proliferating and nonproliferating lymphoid cells.
    Lin H
    Cancer Res; 1973 Jul; 33(7):1716-20. PubMed ID: 4578656
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antineoplastic chemotherapy in dermatology. Clinical experimental and anatomico pathologic study on the activities of some antimitotics. Findings in the general and local therapy].
    Scotti G
    Omnia Med Ther; 1970; 48(3):209-348. PubMed ID: 4108231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.